Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians

Table 2 Effect of respondent variables on proportion of respondents being in consensus on each of the four specific questions related to management of hepatitis C virus infected alcoholic hepatitis patients

Respondent variable	Routine screening for HCV			HCV does not change treatment approach			HCV does not affect response to corticosteroids			HCV does not affect treatmentresponse to pentoxifylline
	n (%)	P value	OR (95%CI)	n (%)	P value	OR (95%CI)	n (%)	P value	OR (95%CI)	n (%)	P value	OR (95%CI)
Age (yr) < 35 35-44 45-54 ≥ 55		0.2			0.7			0.8			0.75
	68 (92)		1	51 (76)		1	54 (83)		1	59 (91)		1
	85 (90)		0.8 (0.3-2.5)	66 (73)		1.3 (0.6-3)	69 (77)		0.6 (0.3-1.3)	79 (89)		0.9 (0.3-2.8)
	99 (96)		2.1 (0.5-8)	73 (78)		0.9 (0.4-2)	75 (81)		0.7 (0.3-1.6)	85 (93)		1.7 (0.5-6)
	88 (97)		2.5 (0.6-11)	58 (72)		1.4 (0.6-3)	63 (79)		0.6 (0.3-1.5)	73 (91)		1.3 (0.4-4.2)
Specialty GE HP		0.37			0.5			0.2			0.55
	183 (93)		1	135 (73)		1	135 (77)		1	160 (92)		1
	157 (95)		1.5 (0.6-3.7)	113 (77)		0.8 (0.5-1.4)	126 (83)		0.7 (0.4-1.2)	136 (90)		1.3 (0.6-2.7)
Patients (n/yr) < 30 ≥ 30		0.29			0.6			0.2			0.38
	299 (93)		1	221 (75)		1	232 (81)		1	259 (91)		1
	41 (98)		2.9 (0.4-22.0)	27 (71)		1.3 (0.6-2.7)	29 (73)		1.6 (0.7-3.3)	37 (95)		0.5 (0.1-2.3)
HCV prevalence < 20% ≥ 20%		0.48			0.3			0.2			0.81
	148 (95)		0.7 (0.3-1.8)	104 (72)		0.8 (0.5-1.3)	119 (83)		1.4 (0.8-2.5)	129 (91)		1.1 (0.5-2.4)
	188 (93)		1	143 (77)		1	141 (77)		1	166 (91)		1

HCV: Hepatitis C virus; GE: Gastroenterology; HP: Hepatology. Also shown are results of logistic regression analyses for each respondent variable given as odds ratio (OR) with 95% confidence interval (CI).